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Background: Domestic dogs are the principal reservoir hosts of Leishmania infantum in regions where visceral
leishmaniasis (VL) is endemic. Although serologic methods are frequently used for the screening of infected dogs,
antibody-based tests require further assessment, due to lack of sensitivity and specificity. In this study, we employed
a multi-antigen printing immunoassay (MAPIA) to compare the antibody responses to novel recombinant proteins
of L. infantum with the potential for the detection of canine VL.
Findings: MAPIA strips were prepared employing 12 recombinant proteins. Antibody reactivity to these antigens
was compared using a panel of sera collected from clinically asymptomatic (n = 16) and symptomatic (n = 41)
culture-positive animals. Our findings showed that the canine immune response to antigen differs between dogs
and depends on infection status. Using this screening assay, when five out of the 12 antigens were combined, an
overall 81% detection rate of L. infantum-infected dogs was achieved.
Conclusions: We conclude that MAPIA is an effective screening tool to rapidly select multiple antigens of
diagnostic utility to be used in a more sensitive point of care diagnostic test such as the Dual-Path Platform (DPP)
multiplex test for the rapid detection of infected dogs.
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Zoonotic visceral leishmaniasis (VL) caused by L. infan-
tum is an important emerging parasitic disease in many
regions [1]. In the neotropics, L. infantum transmission
to humans occurs as a result of Lutzomyia longipalpis
bites [2]. Accordingly, dogs are the major source of L.
infantum for humans; thus, early and accurate detection
of infected dogs is critical to successfully controling the
spread of leishmaniasis [3,4]. Additionally, it is also im-
portant to highlight the value of a reliable test to screen* Correspondence: pveras@bahia.fiocruz.br
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unless otherwise stated.seronegative dogs before vaccination and to confirm in-
fection before culling of seropositive dogs.
Current parasitological diagnostic tests, including
microscopic examination and in vitro culturing, offer
limited sensitivity with respect to the direct detection of
Leishmania. In addition, parasite-specific antibody tests,
such as the immunofluorescent-antibody test [IFAT],
direct agglutination test [DAT], enzyme-linked immuno-
sorbent assay [ELISA], although widely used to diagnose
infection, employ crude antigens derived from whole-
parasite extracts and lack the appropriate sensitivity and
specificity required for accurate serodiagnosis [5-11].
Recently, the use of recombinant protein-based immu-
nochromatographic testing, such as lateral-flow and
Dual-Path Platform (DPP®) technologies, has overcometral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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in the field [6,11-13]. Previous studies have indicated the
promising potential of antigen-based serodiagnostic assays
for VL, employing a cocktail of antigens [14] or chimeric
proteins [15] that cover a broad spectrum of immunoreac-
tivities [16-19]. Although these tests perform well, they do
have limitations; for example, DPP® shows high sensitivity
(98%) and specificity (96%) towards sera from symptom-
atic dogs, but shows a low sensitivity of only 47% towards
sera from asymptomatic dogs [13].
With this in mind, we used the screening test, multi-
antigen print immunoassay (MAPIA), to further char-
acterize antibody responses in order to select those L.
infantum recombinant proteins with a greater capacity to
be utilized for the serodiagnosis of canine visceral leish-
maniasis (CVL). MAPIA is more efficient, cost-effective,
and reproducible than other screening techniques. In
addition, as MAPIA is a membrane-based assay, it can
easily be developed into a rapid test that utilizes thin-layer
immunochromatography, similar to rapid diagnostic tests
for other infectious diseases [20]. This advantage is im-
portant because our future goal is to generate a more reli-
able DPP® assay [13], using MAPIA to carefully select




A set of 12 recombinant L. infantum antigens (rLci1A,
rLci2B, rLci3, rLci4, rLci5, rLci6, rLci7, rLci8, rLci10,
rLci11, rLci12, rLci13) was previously selected from
DNA libraries based on antibody reactivity using sera
from culture-positive dogs [21,22]. Histidine-tagged re-
combinant proteins were produced after sub-cloning
DNA fragments as described previously [21]. The anti-
gens were then purified by affinity chromatography
using PD-10 Desalting Workmate nickel-sepharose col-
umns (Amersham Pharmacia Biotech AB, Sweden), in
accordance with the manufacturer’s instructions.
Dog sera and infection status
A panel of 138 canine sera was used. Negative control
sera were obtained from 40 kennel dogs from Pelotas,
Rio Grande do Sul (a VL-free area of Brazil). These dogs
tested negative for L. infantum via serology, culturing,
and qPCR of splenic aspirate [23]. To test for cross-
reactivity of the 12 recombinant antigens with other
pathogens, we also screened sera from dogs infected
with Leishmania braziliensis (n = 10), Trypanosoma
cruzi (n = 10), Babesia spp. (n = 10), and Ehrlichia canis
(n = 11). To determine sensitivity, the antibody reactivity
was assessed using a panel of 57 sera from symptomatic
(n = 41) and asymptomatic (n = 16) culture-positive
dogs. All infected dogs enrolled in the study were selectedduring epidemiological surveys of CVL carried out in four
endemic areas in Brazil: Camaçari, Bahia; Dias D’Àvila,
Bahia; Jequié, Bahia; and Pancas, Espírito Santo. At the
time of sampling, dogs were clinically examined for seven
typical signs of CVL and were scored clinically as asymp-
tomatic if they had total scores of 0 to 4 and as symptom-
atic if they had scores greater than 4 [8].
MAPIA strip preparation
Antigens were sprayed onto a 0.45-μm, pore-size nitrocel-
lulose membrane (HiFlow Plus HFB24004, Millipore, MA)
in parallel bands via use of a semi-automatic air-brush
printing device (CAMAG automatic TLC sample 4,
CAMAG, Muttenz, Switzerland) with a volume of 5 μL/
mm. As described by Lyashchenko and collaborators [20],
each antigen solution was printed in 15 cm length lines
using the concentration of antigen according to solubility
in phosphate-buffered saline (PBS): Lci1 = 0.236 mg/mL,
Lci2 = 0.222 mg/mL, Lci3 = 0.530 mg/mL, Lci4 = 0.055
mg/mL, Lci5 = 0.139 mg/mL, Lci6 = 0.347 mg/mL, Lci7 =
0.097 mg/mL, Lci8 = 0.125 mg/mL, Lci10 = 0.139 mg/mL,
Lci11 = 0.055 mg/mL, Lci12 = 0.236 mg/mL, Lci13 =
0.180 mg/mL. Three additional lines were saturated with
L. major lysate = 0.7620 mg/mL, recombinant CRA&FRA
T. cruzi proteins = 0.290 mg/mL, and a protein A solution =
0.200 mg/mL. The printed nitrocellulose membranes were
dried in ambient air and cut into 5-mm strips.
Serum incubation and antibody detection
Before incubation with test sera, strips were blocked for
1 h in 800 μl of PBS with 0.3% Tween 20 (Calbiochem,
La Jolla, CA) and 5% instant nonfat dry milk at room
temperature while rocking. Then, the strips were incu-
bated with 1:100 dilution of each serum for 30 min at
room temperature while rocking. After being triple-
washed with PBS-Tween under agitation for 5 min at
37°C, the strips were incubated with 1 mL of goat anti-
dog IgG antibodies conjugated with peroxidase (1:150
dilution), at room temperature for 1 h, and then washed
twice. Enzyme activity was visualized by incubating the
strips for 5 min with 1 mL of substrate-chromogenic so-
lution (5 mg of DAB in 19,995 μL of PBS, with 5 μL of
hydrogen peroxidase). To stop the reaction, the strips
were rinsed extensively in distilled water at room
temperature. The strips were then dried and immedi-
ately stored in dark conditions until the results were
visually read and digitalized.
Data analysis
Test positivity was evaluated by interpretation of serum
antibody reactivity by visual detection of a brown band
on the antigen-impregnated nitrocellulose strips. Epi Info
7 (CDC, Atlanta, Georgia - USA) was used to perform
combinatorial analysis.
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All experiments involving animals were performed in
compliance with Brazilian federal law for animal experi-
mentation (Law 11794). In conformity with the Oswaldo
Cruz Foundation (FIOCRUZ) animal experimentation
guidelines, and according to instructions outlined in the
Brazilian Ministry of Health’s manual for the surveillance
and control of VL. The present study was approved by
the Institutional Review Board (CEUA protocol no. 015/
2009) of the Gonçalo Moniz Research Center in Bahia,
Brazil (CPqGM-FIOCRUZ/BA).
Finding
All MAPIA procedures were optimized with regard to
antigen concentrations and serum dilution (data not
shown). A total of 138 sera from clinically symptomatic
(n = 41) and asymptomatic (n = 16) L. infantum-infected
dogs, healthy controls (n = 40) and animals harboring
other infections (n = 40) were tested against the selected
panel of 12 antigens. The results showed variable antigen
recognition patterns among the evaluated serum sam-
ples, as indicated in Figure 1. As shown in Table 1, the
individual sensitivities of the 12 recombinant proteins
coated onto nitrocellulose membranes ranged from 4 to
58% for identifying parasite-positive dogs. Nonetheless,
each of the antigens detected some positive sera that
others missed. When the individual recombinant pro-
teins were combined, the total sensitivity increased toFigure 1 MAPIA with recombinant Leishmania infantum antigens. Ima
incubated with serum samples from L. infantum-positive dogs (lanes 1, 3–1
positive standard control serum pool (lane 14). The optimum concentration
Lci3 = 0.530 mg/mL, Lci4 = 0.055 mg/mL, Lci5 = 0.139 mg/mL, Lci6 = 0.347 m
Lci11 = 0.055 mg/mL, Lci12 = 0.236 mg/mL, Lci13 = 0.180 mg/mL, L. major ly
mg/mL and protein A solution = 0.200 mg/mL. Antibody reactivity was detec
independent operators. Any visible band in the test area (in addition to the co81% (Figure 2), revealing that the antigens complemen-
ted each other. The well-known heterogeneous humoral
immune response that develops in L. infantum-infected
dogs [24] likely involves multiple antigens that are differ-
entially recognized by the serum of each animal depend-
ing on the state of disease [8]. Therefore, further
research into the development of a more reliable rapid
test based on the combination of multiple antigens in a
DPP format should be pursued.
Efforts to develop a diagnostic test based on antibody-
detection for VL or CVL have been underway for de-
cades although few of such tests are chromatographic
immunoassays currently used in endemic countries
[12,13,25]. Prior studies have demonstrated that anti-
bodies against these antigens are mainly detectable in
cases with advanced stages of disease, while they are
much less detectable in sera from asymptomatic cases
[12,13]. Variable multi-antigen recognition by canine
serum provides an explanation for the variable perform-
ance of commercial tests for detecting infected dogs.
Here, we found the recombinant antigens evaluated were
more sensitive in symptomatic cases (89%) in compari-
son to dogs without signs of VL (56%), thus confirming
that these antigens are differentially recognized at differ-
ent stages of infection. Using MAPIA, the Lci2B and
Lci1A antigens gave the best results in terms of sensitiv-
ity (76% and 71%, respectively) for the detection of dogs
with active disease. Although individually, none of theseges of strips containing printed individual antigens. Strips were
3), serum from a normal control (uninfected) dog (lane 2), and the
of each antigen wereLci1 = 0.236 mg/mL, Lci2 = 0.222 mg/mL,
g/mL, Lci7 = 0.097 mg/mL, Lci8 = 0.125 mg/mL, Lci10 = 0.139 mg/mL,
sate = 0.7620 mg/mL, recombinant CRA&FRA T. cruzi proteins = 0.290
ted as described in Methods. The test bands were visually read by two
ntrol line) was considered a positive reaction.
Table 1 Sensitivity and specificity of MAPIA with recombinant antigens of Leishmania infantum for the serodiagnosis
of canine visceral leishmaniasis
Study groups (n) Reactivity with individual L. infantum antigens (number of positive sera)
Lci1A Lci2B Lci3 Lci4 Lci5 Lci6 Lci7 Lci8 Lci10 Lci11 Lci12 Lci13 Any antigen
Dogs without signs of VL (16) 3 2 4 6 4 1 2 1 4 2 6 1 9
Dogs with signs of VL (41) 29 31 8 15 15 1 9 4 3 8 13 3 37
Total (57) 32 33 12 21 19 2 11 5 7 10 19 4 46
% Sensitivity 56 58 21 37 33 4 19 9 12 18 33 7 81
Normal control (40) 0 1 2 2 2 1 3 1 2 2 4 3 6
Dermal leishmaniasis* (10) 6 3 0 2 2 0 1 0 0 0 0 0 6
Trypanosomiasis* (10) 1 1 1 1 1 0 1 0 1 0 3 0 3
Babesiosis* (10) 1 2 3 3 3 0 1 0 3 1 2 2 4
Ehrlichiosis* (11) 0 0 0 1 1 0 1 0 1 0 1 1 2
Total (81) 8 7 7 11 9 1 7 1 7 3 10 6 21
% Specificity 90 91 91 86 89 99 91 99 91 96 88 93 74
*Sera of dogs affected with other infections.
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(sensitivity ranging from 6 to 38%), 46 out of 57 serum
samples recognized two groups of combined antigens
(namely, rLci1A, rLci2B, rLci8, rLci12 and rLci4 or
rLci1A, rLci2B, rLci8, rLci12 and rLci5), thus improving
the overall sensitivity of the test to 81%. This result is
in agreement with previously published results suggest-
ing that more than one recombinant antigen may be
useful to maximize the sensitivity of diagnostic tests for
CVL [22,26].
As shown in Table 1, the individual antigens displayed
variable specificities (ranging from 86% to 99%). The
rLci1A antigen had a specificity of 90% and the rLci2BFigure 2 Increased diagnostic sensitivity by combining the
individual recombinant antigens for detecting clinically
symptomatic and asymptomatic Leishmania infantum
infected dogs.antigen had a specificity of 91%. These results are in ac-
cordance with previous study, which reported specificity
values of 92% for rLci1A and 95% for rLci2B [27]. In
addition, rLci8, which composes the groups of combined
antigens, also showed a very high specificity value (99%).
By contrast, the other three antigens, rLci4, rLci12 and
rLci5, included in at least one of the two groups of com-
bined antigens, showed lower specificity values of, re-
spectively, 86, 88 and 89%, reducing overall specificity
value to 74% (Table 1).
MAPIA has previously proven to facilitate rapid screen-
ing of antigens, since in comparison to ELISA [20], it is an
easy and rapid test that simultaneously detects the re-
sponse of sera to multiple antigens coated onto a single
nitrocellulose strip. Indeed, the serological performance of
antigens in MAPIA shown to be a good predictor of their
performance in several point-of-care assays [14,15,28].
Here, we reveal MAPIA to be a useful tool for L. infantum
antigen selection for the future development of an immu-
nodiagnostic test for CVL. This screening test allowed the
selection of two sets of antigens (rLci1A, rLci2B, rLci8,
rLci12 and rLci4 or rLci1A, rLci2B, rLci8, rLci12 and
rLci5) offering both high sensitivity and specificity; our re-
sults illustrate the benefit of utilizing a more effective
multi-antigen point-of-care test in DPP format for applica-
tion in mass assessment surveys of L. infantum-exposed
dogs.
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